Eye, Ear, Nose & Throat Conditions
Vitreoretinal dystrophy
Serious
ICD-10: H35 · NIH NLM
हिंदी: आंख का पर्दा रोग · தமிழ்: விழித்திரை நோய் · ಕನ್ನಡ: ರೆಟಿನಾ ರೋಗ · తెలుగు: రెటీనా వ్యాధి · বাংলা: রেটিনার রোগ · मराठी: डोळयाच्या पडद्याचा रोग · ગુજરાતી: રેટિનાનો રોગ
About this condition
Vitreoretinal dystrophy refers to inherited disorders affecting the vitreous gel and retina at the back of the eye. These conditions progressively damage the structures responsible for vision, often beginning in childhood or young adulthood. Regular monitoring by an eye specialist is essential to manage symptoms and preserve remaining vision.
Common symptoms
blurred vision
floaters
difficulty seeing at night
vision loss
distorted vision
poor night vision
When to see a doctor: within 1-2 weeks
This condition in Indian languages
| Hindi (हिंदी) | आंख का पर्दा रोग · धुंधला दिखना · रात में कम दिखना · दृष्टि कमजोर होना |
| Tamil (தமிழ்) | விழித்திரை நோய் · பார்வை மங்கல் · இரவு பார்வை குறைபாடு · பார்வை இழப்பு |
| Kannada (ಕನ್ನಡ) | ರೆಟಿನಾ ರೋಗ · ಮಸುಕಾದ ದೃಷ್ಟಿ · ರಾತ್ರಿ ನೋಡಲು ಕಷ್ಟ · ದೃಷ್ಟಿ ನಷ್ಟ |
| Telugu (తెలుగు) | రెటీనా వ్యాధి · అస్పష్ట దృష్టి · రాత్రి చూడడం కష్టం · దృష్టి కోల్పోవడం |
| Bengali (বাংলা) | রেটিনার রোগ · ঝাপসা দৃষ্টি · রাতে দেখতে অসুবিধা · দৃষ্টিশক্তি হারানো |
| Marathi (मराठी) | डोळयाच्या पडद्याचा रोग · अंधुक दृष्टी · रात्री कमी दिसणे · दृष्टी कमी होणे |
| Gujarati (ગુજરાતી) | રેટિનાનો રોગ · ધૂંધળું દેખાવું · રાત્રે જોવામાં મુશ્કેલી · દૃષ્ટિ ગુમાવવી |
Frequently asked questions
What are the symptoms of Vitreoretinal dystrophy?
blurred vision, floaters, difficulty seeing at night, vision loss, distorted vision, poor night vision.
When should I see a doctor?
within 1-2 weeks
Is Vitreoretinal dystrophy common in India?
This condition is seen across India.
How serious is Vitreoretinal dystrophy?
Severity is classified as Serious. within 1-2 weeks.
Related conditions
Important: This information is for general awareness only and is
not a substitute for professional medical advice. Always consult a qualified doctor.
In an emergency, call 112.
Data sourced from NIH NLM
and MOHFW India.
Full disclaimer